John P. Pribble

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis

Steven M. Opal, Charles J. Fisher, Jean-François Dhainaut et al. · Critical Care Medicine · 1997 · 856 citations

Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock

Steven M. Opal, Patrick J. Scannon, Jean‐Louis Vincent et al. · The Journal of Infectious Diseases · 1999 · 605 citations · Full text

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial

Charles J. Fisher, Gus J. Slotman, Steven M. Opal et al. · Critical Care Medicine · 1994 · 488 citations

Molecular Characterization of the Acute Inflammatory Response to Infections with Gram-Negative versus Gram-Positive Bacteria

Robert J. Feezor, Caroline Oberholzer, Henry V. Baker et al. · Infection and Immunity · 2003 · 242 citations · Full text

Klebsiella Pneumoniae, Immunology, Escherichia Coli +20

Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis.

Andreas Oberholzer, Sonia M Souza, Sven K. Tschoeke et al. · PubMed · 2005 · 223 citations

Inflammation, Prognostic Evaluation, Prognostic Biomarkers +13